Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label on the page updated from v3.6.5 to v3.6.6, indicating a newer page build.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change does not modify substantive content or functionality.SummaryDifference0.1%

- Check51 days agoChange Detected- Revision updated from v3.6.3 to v3.6.4, indicating a minor site update. The change does not alter study content or user-facing functionality.SummaryDifference0.1%

- Check58 days agoChange DetectedStudy timeline details were updated to show actual dates and enrollment, including a Primary Completion date of 2026-12-30 and a Study Completion date of 2027-12-30. Enrollment is now listed as 14, and the status labels indicate actual milestones rather than estimates.SummaryDifference0.6%

- Check73 days agoChange DetectedThe page now reflects a new Revision: v3.6.3, replacing the previous v3.6.2 revision. This is a metadata update indicating a released update to the page content without altering substantive information.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer release of the page template or metadata. This update does not alter the visible content or study details.SummaryDifference0.1%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.